CH618183A5 - - Google Patents

Download PDF

Info

Publication number
CH618183A5
CH618183A5 CH1580574A CH1580574A CH618183A5 CH 618183 A5 CH618183 A5 CH 618183A5 CH 1580574 A CH1580574 A CH 1580574A CH 1580574 A CH1580574 A CH 1580574A CH 618183 A5 CH618183 A5 CH 618183A5
Authority
CH
Switzerland
Prior art keywords
homo
acid
carbon
hydrogen
hydroxy
Prior art date
Application number
CH1580574A
Other languages
German (de)
English (en)
Inventor
Ulrich Dr Kerb
Rudolf Prof Dr Wiechert
Klaus Dr Kieslich
Karl Dr Petzoldt
Helmut Dr Wachtel
Dieter Dr Palenschat
Reinhard Dr Horowski
Gert Dr Paschelke
Wolfgang Dr Kehr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH618183A5 publication Critical patent/CH618183A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
CH1580574A 1973-11-30 1974-11-28 CH618183A5 (en, 2012)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (1)

Publication Number Publication Date
CH618183A5 true CH618183A5 (en, 2012) 1980-07-15

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1580574A CH618183A5 (en, 2012) 1973-11-30 1974-11-28

Country Status (14)

Country Link
US (1) US4045574A (en, 2012)
JP (1) JPS5084561A (en, 2012)
AT (1) AT347611B (en, 2012)
CA (1) CA1030522A (en, 2012)
CH (1) CH618183A5 (en, 2012)
DD (1) DD115659A5 (en, 2012)
DK (1) DK134348C (en, 2012)
ES (1) ES432106A1 (en, 2012)
FR (1) FR2253512B1 (en, 2012)
GB (1) GB1494097A (en, 2012)
IE (1) IE40423B1 (en, 2012)
IL (1) IL46153A (en, 2012)
NL (1) NL7415577A (en, 2012)
SE (1) SE408426B (en, 2012)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
ATE339437T1 (de) * 2002-08-16 2006-10-15 Pharmacia & Upjohn Co Llc 5-androsten-3-olsteroidzwischenprodukte und verfahren zu deren herstellung
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
HRP20190232T1 (hr) 2013-04-17 2019-03-22 Sage Therapeutics, Inc. 19-nor c3,3-disupstituirani c21-n-pirazolil steroidi i postupci za njihovu upotrebu
US9365611B2 (en) 2013-04-17 2016-06-14 Sage Therapeutics, Inc. 19-NOR neuroactive steroids and methods of use thereof
HRP20210610T1 (hr) 2013-07-19 2021-05-28 Sage Therapeutics, Inc. Neuroaktivni steroidi, pripravci i njihove uporabe
EP3831387A1 (en) 2013-08-23 2021-06-09 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
PH12017500711B1 (en) 2014-10-16 2022-12-09 Sage Therapeutics Inc Compositions and methods for treating cns disorders
EP3719029A1 (en) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Compositions for inducing sedation
PT3250210T (pt) 2015-01-26 2021-03-26 Sage Therapeutics Inc Composições e métodos para o tratamento de distúrbios do snc
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2017296295B2 (en) 2016-07-11 2022-02-24 Sage Therapeutics, Inc. C7, C12, and C16 substituted neuroactive steroids and their methods of use
EP3481845B1 (en) 2016-07-11 2023-09-13 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
AR114044A1 (es) * 2017-12-22 2020-07-15 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos en el sistema nervioso central
BR112021010996A2 (pt) 2018-12-05 2021-08-31 Sage Therapeutics, Inc. Esteroides neuroativos e seus métodos de uso
EP3976628A1 (en) 2019-05-31 2022-04-06 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof
US20230085354A1 (en) * 2019-06-27 2023-03-16 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
WO2020264512A1 (en) * 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compounds for treating cns disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
IE40423B1 (en) 1979-05-23
JPS5084561A (en, 2012) 1975-07-08
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
DK604174A (en, 2012) 1975-07-28
SE7414960L (en, 2012) 1975-06-02
DD115659A5 (en, 2012) 1975-10-12
FR2253512B1 (en, 2012) 1978-02-03
DK134348B (da) 1976-10-25
SE408426B (sv) 1979-06-11
AT347611B (de) 1979-01-10
DK134348C (da) 1977-03-21
CA1030522A (en) 1978-05-02
AU7586774A (en) 1976-06-03
NL7415577A (nl) 1975-06-03
ATA950774A (de) 1978-05-15
GB1494097A (en) 1977-12-07
US4045574A (en) 1977-08-30
IL46153A0 (en) 1975-02-10
FR2253512A1 (en, 2012) 1975-07-04
IL46153A (en) 1979-01-31

Similar Documents

Publication Publication Date Title
CH618183A5 (en, 2012)
CH619268A5 (en, 2012)
DE2360443A1 (de) D-homo-20-ketopregnane
DE2636405C2 (de) Δ↑1↑↑5↑-17α-Chloräthinyl- und -Propinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
DE2445161A1 (de) D-homo-20-ketopregnane ii
DE1277253B (de) Ungesaettigte 16-Methylen-17ª‡-alkoxy-3, 20-diketo-steroide der Pregnanreihe sowie ein Verfahren zu ihrer Herstellung
DE2636404C2 (de) Δ↑1↑↑5↑-17α-Äthinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
DE2453823A1 (de) Neue methylensteroide
DE2047071C3 (de) pregnadiene, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1113690B (de) Verfahren zur Herstellung von in 11-Stellung durch sauerstoffhaltige Gruppen substituierten 16-Methyl-1, 4-pregnadien-17ª‡-ol-3, 20-dion-Verbindungen
AT254407B (de) Herstellung von Retrosteroiden
DE2651364A1 (de) Neue d-homosteroide
DE2506688A1 (de) D-homo-19-nor-20-ketopregnane und verfahren zu ihrer herstellung
DE2449327A1 (de) 7-hydroxy-oestradiole
DE2636407A1 (de) Delta hoch 15 -steroide
DE1170950B (de) Verfahren zur Herstellung von 16ª‡-Chlormethyl-?-pregnadien-11ª‰, 21-diol-3, 20-dion und seiner 21-Ester
CH617709A5 (en, 2012)
DE1254148B (de) Verfahren zur Herstellung von 1-Dehydro-3-methylen-steroiden der Androstanreihe
DE1095276B (de) Verfahren zur Herstellung von therapeutisch wirksamen Steroidverbindungen
DE1195747B (de) Verfahren zur Herstellung neuer 16-Methylen-testosteron-derivate
DE1232141B (de) Verfahren zur Herstellung von in 16-Stellung substituierten 15-Dehydro-steroiden
DE1230798B (de) Verfahren zur Herstellung von delta 4- bzw. delta 1,4-9alpha-Fluor-16-halogenmethylen-3, 20-diketosteroiden
CH349978A (de) Verfahren zur mikrobiologischen 1-Dehydrierung von Steroiden
DE1212528B (de) Verfahren zur Herstellung von delta 1,4,6-16-Methylen-3, 20-diketo-steroiden
DE1222497B (de) Verfahren zur Herstellung von 17alpha-AEthoxy-6-chlor-6-dehydro-progesteron

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased